Twenty-four-hour ambulatory blood pressure monitoring in hypertension: An evidence-based analysis

Ontario Health Technology Assessment Series

Volumn 12, Issue 15, 2012, Pages 1-65

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BUDGET; CANADA; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEVICE SAFETY; HEART AUSCULTATION; HUMAN; HYPERTENSION; INCIDENCE; MORTALITY; OSCILLOMETRY; POLYPHARMACY; PREVALENCE; PROGNOSIS; SPHYGMOMANOMETER; WHITE COAT HYPERTENSION; AMBULATORY CARE; BLOOD PRESSURE; COMPARATIVE STUDY; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; REVIEW;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; MONITORING, PHYSIOLOGIC; OFFICE VISITS; WHITE COAT HYPERTENSION;

EID: 84877018609     PISSN: 19157398     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Public Health Agency of Canada. Hypertension [Internet]. [updated 2011 Jun 11; cited 2011 Sep 20]. Available from: http://www.phac-aspc.gc.ca/cd-mc/cvd-mcv/hypertension-eng.php
2. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005 Feb 8;111(5):697-716.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003 Dec;42(6):1206-52.
4. National Heart Lung and Blood Institute. High Blood Pressure [Internet]. [updated 2011 Apr 1; cited 2011 Oct 31]. Available from: http://www.nhlbi.nih.gov/health/health-topics/topics/hbp/
5. Waeber B, Mourad J-J, O'Brien E. Nighttime blood pressure: A target for therapy? Curr Hypertens Rep. 2010;12(6):474-9.
6. Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada, 2010 [Internet]. Ottawa, ON: Chronic Disease Surveillance Division; 2010 Jan 1 [cited: 2011 Sep 21]. 28 p. Available from: http://www.phac-aspc.gc.ca/cdmc/cvd-mcv/ccdss-snsmc-2010/pdf/CCDSS_HTN_Report_FINAL_EN_20100513.pdf
7. Public Health Agency of Canada. Hypertension Facts and Figures [Internet]. [updated 2010 Jul 22; cited 2011 Sep 20]. Available from: http://www.phac-aspc.gc.ca/cd-mc/cvdmcv/hypertension_figures-eng.php
8. Chavanu K, Merkel J, Quan AM. Role of ambulatory blood pressure monitoring in the management of hypertension. Am J Health Syst Pharm. 2008 Feb 1;65(3):209-18.
9. Myers MG. Pseudoresistant hypertension attributed to white-coat effect. Hypertension. 2012 Mar;59(3):532-3.
10. Myers MG. Implications of ambulatory blood pressure monitoring substudies on the interpretation of clinical trials in hypertension: should the threshold for drug therapy be lower in older patients? J Clin Hypertens. 2011 Oct;13(10):703-5.
11. Floras JS, Jones JV, Hassan MO, Osikowska B, Sever PS, Sleight P. Cuff and ambulatory blood pressure in subjects with essential hypertension. Lancet. 1981 Jul 18;2(8238):107-9.
12. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Grant FC, et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: Randomised parallel design controlled trial. BMJ. 2011;342(d286):1-9.
13. Parati G, Pomidossi G, Casadei R, Mancia G. Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pressure monitoring. Hypertension. 1985 Jul;7(4):597-601.
14. Myers MG, Reeves RA, Oh PI, Joyner CD. Overtreatment of hypertension in the community? Am J Hypertens. 1996 May;9(5):419-25.
15. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011 Jan;24(1):52-8.
16. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ. 2001 Mar 3;322(7285):531-6.
17. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FDR, Deeks JJ, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: Systematic review. BMJ. 2011;342(d3621):1-17.
18. White WB. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day. Am J Med. 2008 Aug;121(8 Suppl):S2-S7.
19. Myers MG. Recent advances in automated blood pressure measurement. Curr Hypertens Rep. 2008 Oct;10(5):355-8.
20. O'Brien E, Beevers G, Lip GY. ABC of hypertension. Blood pressure measurement. Part IIIautomated sphygmomanometry: ambulatory blood pressure measurement. BMJ. 2001 May 5;322(7294):1110-4.
21. O'Brien E. The circadian nuances of hypertension: A reappraisal of 24-h ambulatory blood pressure measurement in clinical practice. Ir J Med Sci. 2007;176(2):55-63.
22. Appel LJ, Robinson KA, Guallar E, Erlinger T, Masood SO, Jehn M, et al. Utility of blood pressure monitoring outside of the clinic setting (Structured abstract). Agency for Healthcare Research and Quality. 2002;301.
23. Myers MG, Godwin M. Automated Office Blood Pressure. Can J Cardiol. 2012 Jan 18;28(2):1-6.
24. Myers MG, Godwin M, Dawes M, Kiss A, Tobe SW, Kaczorowski J. Measurement of blood pressure in the office: recognizing the problem and proposing the solution. Hypertension. 2010 Feb;55(2):195-200.
25. Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, et al. Grading quality of evidence and strength of recommendations. BMJ. 2004 Jun 19;328(7454):1490.
26. National Institute for Health and Clinical Excellence. Hypertension: the clinical management of primary hypertension in adults [Internet]. London: National Clinical Guideline Centre; 2011 Aug 1 [cited: 2011 Sep 20]. 328 p. 127. Available from: http://guidance.nice.org.uk/nicemedia/live/13561/56007/56007.pdf
27. Conen D, Tschudi P, Martina B. Twenty-four hour ambulatory blood pressure for the management of antihypertensive treatment: a randomized controlled trial. J Hum Hypertens. 2009;23(2):122-9.
28. Bisset AF. Ambulatory versus conventional blood pressure monitoring (Structured abstract). London: Bazian Ltd, Wessex Institute for Health Research and Development, University of Southampton. 2001;8.
29. Canadian Coordinating Office for Health Technology Assessment. 24-hour ambulatory blood pressure monitoring (Brief record) [Internet]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2003 Jan 1 [cited: 2012 Mar 26]. 9 p. 15. Available from: http://www.cadth.ca/media/pdf/241_No15_24hourBP_preassess_e.pdf
30. Schrader J, Luders S, Zuchner C, Herbold M, Schrandt G. Practice vs ambulatory blood pressure measurement under treatment with ramipril (PLUR Study): A randomised, prospective long-term study to evaluate the benefits of ABPM in patients on antihypertensive treatment. J Hum Hypertens. 2000;14(7):435-40.
31. Staessen JA, Byttebier G, Buntinx F, Celis H, O'Brien ET, Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators. JAMA. 1997 Oct 1;278(13):1065-72.
32. Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Vari N, Ferrara R, et al. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Clin Ther. 2004 Sep;26(9):1436-45.
33. Quinn RR, Hemmelgarn BR, Padwal RS, Myers MG, Cloutier L, Bolli P, et al. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2010;26(5):241-8.
34. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004 Mar;22(3):435-45.
35. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006 Jun 1;354(22):2368-74.
36. Staessen JA. Ambulatory blood pressure in clinical trials. Blood Press Monit. 2000;5(1):39-41.
37. Madsen LB, Christiansen T, Kirkegaard P, Pedersen EB. Economic evaluation of home blood pressure telemonitoring: A randomized controlled trial. Blood Press. 2011;20(2):117-25.
38. Reed SD, Li Y, Oddone EZ, Neary AM, Orr MM, Grubber JM, et al. Economic evaluation of home blood pressure monitoring with or without telephonic behavioral self-management in patients with hypertension. Am J Hypertens. 2010;23(2):142-8.
39. Fukunaga H, Ohkubo T, Kobayashi M, Tamaki Y, Kikuya M, Obara T, et al. Cost-effectiveness of the introduction of home blood pressure measurement in patients with office hypertension. J Hypertens. 2008 Apr;26(4):685-90.
40. Funahashi J, Ohkubo T, Fukunaga H, Kikuya M, Takada N, Asayama K, et al. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension. Blood Press Monit. 2006 Oct;11(5):257-67.
41. Krakoff LR. Cost-effectiveness of ambulatory blood pressure: A reanalysis. Hypertension. 2006;47(1):29-34.
42. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Cost-effectiveness of options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011 Oct 1;378(9798):1219-30.
43. Canadian Agency for Drugs and Technologies in Health. Guidelines for the Economic Evaluation of Health Technologies: Canada [Internet]. Canada: Canadian Agency for Drugs and Technologies in Health; 2006 Mar 31 [cited: 2012 Jan 10]. 9 p. Available from: http://cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf
44. Canadian Human Mortality Database. Ontario Life Tables 2005-2007 by 1-Year Age Groups [Internet] [Internet]. [updated 2010 Jul 8; cited 2011 Nov 25]. Available from: http://www.bdlc.umontreal.ca/chmd/prov/ont/ont.htm
45. de Oliveira C, Wijeysundera H, Tobe S, Moy Lum-Kwong M, Von Sychowski S, Wang X, et al. Economic Analysis of Heart and Stroke Foundation of Ontario Hypertension Management Initiative (in press). Ontario: Heart and Stroke Foundation of Ontario; 2011 [cited: 2011]. 0 p.
46. D'Agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008 Feb 12;117(6):743-53.
47. Statistics Canada. Deaths and mortality rate, by selected grouped causes and sex, Canada, provinces and territories, annual [Internet]. [updated 2011 Oct 17; cited 2011 Nov 23]. Available from: http://www5.statcan.gc.ca/cansim/pickchoisir?lang=eng&searchTypeByValue=1&id=1020552
48. Kind P, Dolan P, Gudex C, Williams A. Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998 Mar 7;316(7133):736-41.
49. Melsop KA, Boothroyd DB, Hlatky MA. Quality of life and time trade-off utility measures in patients with coronary artery disease. Am Heart J. 2003 Jan;145(1):36-41.
50. Tengs TO, Lin TH. A meta-analysis of quality-of-life estimates for stroke. Pharmacoeconomics. 2003;21(3):191-200.
51. Goodacre S, Nicholl J, Dixon S, Cross E, Angelini K, Arnold J, et al. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ. 2004 Jan 31;328(7434):254.
52. Ontario Ministry of Health and Long-Term Care. Ontario Health Insurance Schedule of Benefits and Fees [Internet]. [updated 2011 Dec 21; cited 2011 Oct 11]. Available from: http://www.health.gov.on.ca/english/providers/program/ohip/sob/sob_mn.html
53. Saskatchewan Ministry of Health. Physician Payment Schedule [Internet]. [updated 2011 Nov 10; cited 2011 Nov 11]. Available from: http://www.health.gov.sk.ca/payment-schedule-oct2011
54. Ontario Ministry of Finance. Ontario Population Projections Update (Table 8) [Internet]. [updated 2011; cited 2011 Oct 11]. Available from: http://www.fin.gov.on.ca/en/economy/demographics/projections/
55. Statistics Canada. Health indicator profile, two year period estimates, by age group and sex, Canada, provinces, territories, health regions (2011 boundaries) and peer groups, occasional [Internet]. [updated 2012 Jan 23; cited 2012 Jan 23]. Available from: http://www5.statcan.gc.ca/cansim/a05?lang=eng&id=1050502&paSer=&pattern=Table+105-0502&stByVal=1&csid=
56. Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012 Feb;30(2):253-66.